Dr Karin Kassahn PhD FFSc (RCPA)
- Head, Technology Advancement Unit, SA Pathology
- Affiliate, School of Biological Sciences, University of Adelaide
Karin is Head of the Technology Advancement Unit which works with laboratories across SA Pathology to translate genomic approaches to routine clinical care. In 2015, SA Pathology was the first laboratory in Australia to receive accreditation for clinical whole-exome testing. Karin’s research interests are understanding the molecular changes driving human disease and clinical bioinformatics. She has expertise in quality control and validation of next-generation sequencing assays for diagnostics use. She participates in national activities to set standards for the application of next-generation sequencing in clinical care and is an investigator in the Australian Genomics Health Alliance.
Prior to joining SA Pathology, Karin held a post-doctoral position with Prof Sean Grimmond as part of the International Cancer Genome Sequencing Consortium (ICGC), investigating the molecular changes driving pancreatic and ovarian cancer. Karin undertook postdoctoral studies in comparative genome evolution at the Institute of Molecular Bioscience, The University of Queensland under mentorship of Prof Mark Ragan.
Karin was awarded her PhD in 2007 from James Cook University. In 2015, she was admitted as a Fellow of the Faculty of Science of the Royal Society of Pathologists of Australasia (RCPA) by Research. She is a member of the Human Genetics Society of Australasia (HGSA) and the special interest group in Diagnostics Genomics.
Locations: SA Pathology, Adelaide University
Specialties: Diagnostic Genomics, Bioinformatics